Aiom: “Adjuvant therapy for breast cancer can change clinical practice”

Saverio Cinieri, president of Aiom at the Asco Congress: “Adjuvant therapy with ribociclib represents another great step forward for clinical research and the treatment of breast cancer. Italy played an important role in the phase III international study Natalee”.